Mohamad H. Yamani - Concepedia

Author

Mohamad H. Yamani

Also Known As

M H Yamani, M Yamani, M. H. YAMANI, M. H. Yamani, M.H Yamani, M.H. Yamani, M.Hilal Yamani, Mahmoud Yamani, Manal Yamani, Mohamad H Yamani

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Cleveland Foundation

About

Mohamad H. Yamani is an author at Cleveland Clinic specializing in medicine, cardiology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	1.3K
2	Engineering	3	3	124
3	Health Sciences	3	3	71
4	Public Health	3	3	60
5	Natural Sciences	1	1	11

Mohamad H. Yamani

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation Showkat A. Haji, Randall C. Starling, Robin K. Avery, The Journal of Heart and Lung Transplantation TransplantationCardiovascular DiseaseSolid Organ TransplantationImmunologyHepatitis	2004	142
Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants1 Nader Fahmy, Mohamad H. Yamani, Randall C. Starling, Transplantation	2003	111
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact Mohamad H. Yamani, Showkat A. Haji, Randall C. Starling, American Heart Journal Heart FailureHemodynamic EfficacyCardiogenic ShockCardiovascular DiseaseMilrinone-based Therapy	2001	93
THE IMPACT OF ROUTINE MYCOPHENOLATE MOFETIL DRUG MONITORING ON THE TREATMENT OF CARDIAC ALLOGRAFT REJECTION Mohamad H. Yamani, Randall C. Starling, Marlene Goormastic, Transplantation	2000	90
Improved Survival After Acute Myocardial Infarction Complicated by Cardiogenic Shock With Circulatory Support and Transplantation: Comparing Aggressive Intervention With Conservative Treatment Wakkas Tayara, Randall Starling, Mohamad H. Yamani, The Journal of Heart and Lung Transplantation Cardiogenic ShockTransplantationCardiovascular DiseaseComparing Aggressive InterventionCirculatory Support	2006	81
Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome Mohamad H. Yamani, Showkat A. Haji, Randall C. Starling, Journal of the American College of Cardiology Myocardial Ischemic-fibrotic InjuryHeart FailureTransplantationCardiovascular DiseaseCellular Rejection	2002	80
Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection Mohamad H. Yamani, Robin K. Avery, Steven D. Mawhorter, The Journal of Heart and Lung Transplantation Transplant RejectionHeart FailureTransplantationMedicineHematology	2001	74
The Effect of Combined Angiotensin-Converting Enzyme Inhibition and Calcium Antagonism on Allograft Coronary Vasculopathy Validated by Intravascular Ultrasound Kürşad Erinç, Mohamad H. Yamani, Randall C. Starling, The Journal of Heart and Lung Transplantation Heart FailureVascular DiseaseEngineeringCardiovascular DiseaseAtherosclerosis	2005	64
Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts Nader Fahmy, Mohamad H. Yamani, Randall C. Starling, Transplantation	2003	62
Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study Javier Jiménez, Samir R Kapadia, Mohamad H. Yamani, The Journal of Heart and Lung Transplantation TransplantationCellular RejectionGraft SurvivalVascular BiologyTransplant Arteriopathy	2001	60

Page 1